Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|October 23, 2020

Outside of Treatment in Metastatic Breast Cancer

Author(s)Kristie L. Kahl
Advertisement

Episodes in this series

Kristie L. Kahl and Jamil Rivers
EP. 1 Treatment for Metastatic Breast Cancer
Kristie L. Kahl and Jamil Rivers
EP. 2 Joining a Clinical Trial
EP. 3 Addressing Disparities in Metastatic Breast Cancer
EP. 3 Addressing Disparities in Metastatic Breast Cancer
Kristie L. Kahl and Kate Watson
Now Playing
EP. 4 Outside of Treatment in Metastatic Breast Cancer
EP. 5 Talking with Your Family About Metastatic Breast Cancer
EP. 5 Talking with Your Family About Metastatic Breast Cancer

Advertisement
Metastatic Breast Cancer
|
Learning the Ins and Outs of Metastatic Breast Cancer
|
METAvivor

Related Content

Advertisement
"FDA" text.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

ByAlex Biese
December 15th 2025
Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick
December 12th 2025
Enhertu and Perjeta led to better quality-of-life and less side effects than standard-of-care among patients with HER2+ advanced or metastatic breast.

Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

ByPaige Britt
December 11th 2025
Inluriyo, an oral therapy for ER+, HER2– metastatic breast cancer with ESR1 mutations, offers a new treatment option after prior endocrine therapy.

FDA Approves Inluriyo for ER+, HER2– Metastatic Breast Cancer

BySpencer Feldman
September 25th 2025
Image of women with pink cap.

A Patient Guide to Understanding HER2-Positive Breast Cancer

BySpencer Feldman
September 19th 2025
Advertisement
Advertisement

Trending on CURE

1

"You Think It Won't Happen to You" — Teddi Mellencamp on Melanoma and Speaking Up

2

Reclaim Your Strength: Simple At-Home Exercise for Cancer Patients & Survivors

3

Living with Metastatic Cancer Means Loss in the Midst of Love

4

10 Things That Got Me Through Treatment ft. Kiana Wooten

5

Why I Don't Say 'Cancer-Free': Superstition, N.E.D. and the Evil Eye

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.